Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure

Overview of attention for article published in JACC: Heart Failure, August 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 2 news outlets
policy: 2 policy sources
twitter: 166 X users

facebook: 2 Facebook pages
f1000: 1 research highlight platform

Citations

dimensions_citation: 59 Dimensions

Readers on

mendeley: 136 Mendeley

Summary News Policy documents X Facebook Research highlights Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Lipids in Walnut Trial; Watchman Leak Aftermath; Not Even 1 Drink a Month in Afib?

MedPage Today, 31 Aug 2021

Cardiology > Prevention Recent developments of interest in cardiovascular medicine CDC reports no deaths from myocarditis…

Dapagliflozin benefits wide range of people with CKD

medwireNews, 27 Aug 2021

medwireNews: Dapagliflozin reduces the risk for kidney failure, heart failure (HF) hospitalization, and death in people with…